Posted by Michael Wonder on 17 May 2022
Health economic assessment of Xevudy for the treatment of COVID-19
17 May 2022 - TLV has produced a health economic assessment for the regions for the drug Xevudy (sotrovimab).
Xevudy is used for the treatment of coronavirus disease 2019 (COVID-19) in adults and adolescents 12 years and older who do not need oxygen supply and who have an increased risk of developing severe COVID-19.
